Media Centre
Latest press releases
-
H1 and Q2 2025 results
-
Imfinzi granted Priority Review and Breakthrough Therapy Designation in the US for patients with resectable early-stage gastric and gastroesophageal junction cancers
-
Trixeo Aerosphere receives positive EU CHMP opinion as first inhaled medicine using next-generation propellant with near-zero Global Warming Potential
-
Gefurulimab dual-binding nanobody demonstrated statistically significant and clinically meaningful improvement in functional activities of daily living in adults with generalised myasthenia gravis in PREVAIL Phase III trial
-
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
